Altman Advisors’s Allergan plc AGN Stock Holding History

Altman Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,289	Closed	-$865K	–	82
2017 Q4	$865K	Buy	+5,289	New	+$949K	0.75%	52

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Altman Advisors's AGN Position: Q1 2018 in Review

Altman Advisors sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 5,289 shares — an estimated $865K sold.

Altman Advisors first reported a position in AGN in Q4 2017 and held it in 1 quarter. The position peaked at $865K in Q4 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

Altman Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Altman Advisors sold 5,289 Allergan plc shares in Q1 2018, an estimated $865K.
Altman Advisors first reported a position in Allergan plc in Q4 2017 and held it in 1 quarter.
Altman Advisors's Allergan plc position peaked at $865K in Q4 2017.
1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Altman Advisors's 13F filing for Q1 2018, filed 27 Apr 2018.